Alcohol and Cardiovascular Mortality

  • Michael H. Criqui
Part of the NATO ASI Series book series (NSSA, volume 84)


Although effects of alcohol on the cardiovascular system have been recognized for more than a century (Friedreich, 1861), only in recent years has the complexity of the association of ethanol consumption with cardiovascular disease (CVD) morbidity and mortality begun to be appreciated. Much recent work has detailed the direct effects of ethanol on the myocardium and its conduction system, the striking associations of alcohol with certain physiologic and biological variables influencing atherosclerosis, and the association in epidemiologic studies between ethanol and subsequent morbidity and mortality. In this chapter we intend to review the direct effects of alcohol on the heart; the apparent alcohol effects on certain cardiovascular risk factors such as lipids, blood pressure, thrombogenesis, and stress; alcohol’s association with cardiovascular mortality; and the implications of such findings for public health policy.


Alcohol Consumption Cardiovascular Mortality Heavy Drinker Hemorrhagic Stroke Ethanol Consumption 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander, C. S. Idiopathic heart disease I. Analysis of 100 cases with special reference to chronic alcoholism. American Journal of Medicine 41 (1966) 213–228.PubMedCrossRefGoogle Scholar
  2. Barr, D. P., Russ, E. M., and Eder, H. A. Protein-lipid relationships in human plasma. American Journal of Medicine 11 (1951) 480–493.PubMedCrossRefGoogle Scholar
  3. Beevers, D. G. Alcohol and hypertension. Lancet 2 (1977) 114–115.PubMedCrossRefGoogle Scholar
  4. Belizan, J. M. et al. Reduction of blood pressure with calcium supplementation in young adults. Journal of the American Medical Association 249 (1983) 1161–1165.PubMedCrossRefGoogle Scholar
  5. Carlsson, C. and Haggendal, J. Arterial noradrenaline levels after ethanol withdrawal. Lancet 2 (1967) 889.PubMedCrossRefGoogle Scholar
  6. Castelli, W. P. et al. Alcohol and blood lipids: The Cooperative Lipoprotein Phenotyping Study. Lancet 2 (1977) 153–155.PubMedCrossRefGoogle Scholar
  7. Centerwall, B. S. and Criqui, M. H. Prevention of the Wernicke-Korsakoff syndrome: A cost-benefit analysis. New England Journal of Medicine 299 (1978) 285–289.PubMedCrossRefGoogle Scholar
  8. Clark, L. T. and Friedman, H. S. Alcohol-induced hypertension: Assessment of mechanisms and complications. Presented at the 32nd Annual Scientific Session of the American College of.Cardiology, New Orleans, Louisiana, 1983.Google Scholar
  9. Criqui, M. H. et al. Frequency and clustering of other coronary risk factors in dyslipoproteinemias. Presented at the Annual Scientific Sessions of the American College of Cardiology, New Orleans, Louisiana, 1983.Google Scholar
  10. Criqui, M. H. et al. Cigarette smoking, alcohol consumption, and cardiovascular mortality: The Lipid Research Clinics Follow-Up Study. (Abstract) Circulation 66 (1982) (Suppl. II), II–235.Google Scholar
  11. Criqui, M. H. et al. Alcohol consumption and blood pressure: The Lipid Research Clinics Prevalence Study. Hypertension 3 (1981) 557–565.PubMedGoogle Scholar
  12. Demakis, J. G. et al. The natural course of alcoholic cardiomyopathy. Annals of Internal Medicine 80 (1974) 293–297.PubMedGoogle Scholar
  13. Deykin, D., Janson, P., and McMahon, L. Ethanol potentiation of aspirin-induced prolongation of the bleeding time. New England Journal of Medicine 306 (1982) 852–854.PubMedCrossRefGoogle Scholar
  14. Dyer, A. R. et al. Alcohol consumption and 17-year mortality in the Chicago Western Electric Company Study. Preventive Medicine 9 (1980) 78–90.PubMedCrossRefGoogle Scholar
  15. Ettinger, P. O. et al. Arrhythmias and the “holiday heart”: Alcohol-associated cardiac rhythm disorders. American Heart Journal 95 (1978) 555–562.PubMedCrossRefGoogle Scholar
  16. Fisher, V. J. and Favaler, F. The action of ethanol upon the action potential and contraction of ventricular muscle. Recent Advances in Studies on Cardiac Structure and Metabolism 5 (1975) 415–422.PubMedGoogle Scholar
  17. Friedreich, N. Handbuch der speziellen Pathologie und Therapies. 5th Sect. Krankheiten des Herzens, Ferdinand Enke, Erlangen, 1861.Google Scholar
  18. Goodwin, D. W. Hereditary factors in alcoholism. Hospital Practice 13 (1978) 121–130.PubMedGoogle Scholar
  19. Gordon, T. et al. High-density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. American Journal of Medicine 62 (1977) 707–714.PubMedCrossRefGoogle Scholar
  20. Gould, L. et al. Electrophysiologic properties of alcohol in man. Journal of Electrocardiology 11 (1978) 219–226.PubMedCrossRefGoogle Scholar
  21. Greenspan, A. J., Stang, J. M., Lewis, R. P., and Schaal, S. F. Provocation of ventricular tachycardia after consumption of alcohol. New England Journal of Medicine 301 (1979) 1049–1050.CrossRefGoogle Scholar
  22. Haffner, S., Appelbaum-Bowden, D., Hoover, J., and Haggard, W. Association of high-density lipoprotein cholesterol 2 and 3 with Quetelet, alcohol, and smoking: The Seattle Lipid Research Clinic Population. (Abstract) CVD Epidemiology Newsletter 31 (1982) 20.Google Scholar
  23. Hartz, A. J. et al. Risk factors for myocardial infarction independent of coronary artery disease. (Abstract) Circulation 60 (1979) (Suppl. II), II–258.Google Scholar
  24. Haselager, E. M. and Vreeken, J. Rebound thrombocytosis after alcohol abuse: A possible factor in the pathogenesis of thromboembolic disease. Lancet 1 (1977) 774–775.PubMedCrossRefGoogle Scholar
  25. Haskell, W., Krauss, R., Wood, P., and Lindgren F. The negative relationship between moderate alcohol intake and coronary heart disease may not be due to elevated serum HDL2. (Abstract) CVD Epidemiology Newsletter 31 (1982) 23.Google Scholar
  26. Haut, M. J. and Cowan, D. H. The effect of ethanol on hemostatic properties of human blood platelets. American Journal of Medicine 56 (1974) 22–33.PubMedCrossRefGoogle Scholar
  27. Hennekens, C. H. et al. Effects of beer, wine and liquor in coronary deaths. Journal of the American Medical Association 242 (1979) 1973–1974.PubMedCrossRefGoogle Scholar
  28. Hepner, G. W., Roginsky, M., and Moos, H. F. Abnormal vitamin D metabolism in patients with cirrhosis. American Journal of Digestive Diseases 21 (1976) 527–532.PubMedCrossRefGoogle Scholar
  29. Hillbom, M. and Kaste, M. Does ethanol intoxication promote brain infarction in young adults? Lancet 2 (1978) 1181–1183.PubMedCrossRefGoogle Scholar
  30. Hulley, S. B., Rosenman, R. H., Bawol, R. D., and Brand, R. J. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary disease. New England Journal of Medicine 302 (1980) 1383–1389.PubMedCrossRefGoogle Scholar
  31. Jenkins, C. D. Recent evidence supporting psychologic and social risk factors for coronary disease. New England Journal of Medicine 294 (1976) 987–994, 1033–1038.PubMedCrossRefGoogle Scholar
  32. Jones, B., Barrett-Connor, E., Criqui, M. H., and Holdbrook, M. J. Caloric and nutrient intake in drinkers and non-drinkers of alcohol: A community study. American Journal of Clinical Nutrition 35 (1982) 135–139.PubMedGoogle Scholar
  33. Kagan, A., Yano, K., Rhoads, G. G., and McGee, D. L. Alcohol and cardiovascular disease: The Hawaiian experience. Circulation 64 (1981) (Suppl. III), III-27–III-31.PubMedGoogle Scholar
  34. Kannel, W. B. Coffee, cocktails, and coronary candidates (editorial). New England Journal of Medicine 297 (1977) 443–444.PubMedCrossRefGoogle Scholar
  35. Keys, A. et al. Mortality and coronary heart disease among men studied for 23 years. Archives of Internal Medicine 128 (1971) 201–214.PubMedCrossRefGoogle Scholar
  36. Klatsky, A. L., Friedman, G. D., and Siegelaub, A. B. Alcohol consumption before myocardial infarction. Annals of Internal Medicine 81 (1974) 294–301.PubMedGoogle Scholar
  37. Klatsky, A. L., Friedman, G. D., and Siegelaub, A. B. Alcohol use and cardiovascular disease: The Kaiser-Permanente experience. Circulation 64 (1981a) (Suppl. III): III-32–III-41).PubMedGoogle Scholar
  38. Klatsky, A. L., Friedman, G. D., and Siegelaub, A. B. Alcohol and mortality: A ten-year Kaiser-Permanente experience. Annals of Internal Medicine 95 (1981b) 139–145.PubMedGoogle Scholar
  39. Klatsky, A. L., Friedman, G. D., Siegelaub, A. B., and Gerard, M. J. Alcohol consumption and blood pressure: Kaiser-Permanente multiphasic health examination data. New England Journal of Medicine 296 (1977) 1194–1200.PubMedCrossRefGoogle Scholar
  40. Korsan-Bengsten, K., Wilhelmsen, L., and Tibblin, G. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old: II. Relations of the variables to “risk factors” for myocardial infarction. Thrombosis et Diathesis Haemorrhagica 28 (1972) 99–108.Google Scholar
  41. Kozarevic, D. et al. Drinking habits and coronary heart disease: The Yugoslavia Cardiovascular Disease Study. American Journal of Epidemiology 116 (1982) 748–758.PubMedGoogle Scholar
  42. Kozarevic, D. et al. Frequency of alcohol consumption and morbidity and mortality. Lancet 1 (1980) 613–616.CrossRefGoogle Scholar
  43. Krawitt, E. L. Effect of ethanol ingestion on duodenal calcium transport. Journal of Laboratory and Clinical Medicine 85 (1975) 665–671.PubMedGoogle Scholar
  44. Kuller, L. and Castelli, W. High HDL levels can unmask covert alcoholic. Skin and Allergy News 11 (1980) 25.Google Scholar
  45. Kuller, L., Perper, J. A., Cooper, M., and Fisher, R. An epidemic of deaths attributed to fatty liver in Baltimore. Preventive Medicine 3 (1974) 61–79.PubMedCrossRefGoogle Scholar
  46. Lifton, L and Scheig, R. Ethanol-induced hypertriglyceridemia prevalence and contributing factors. American Journal of Clinical Nutrition 31 (1978) 614–618.PubMedGoogle Scholar
  47. Lindenbaum, J. and Hargrove, R. L. Thrombocytopenia in alcoholics. Annals of Internal Medicine 68 (1968) 526–532.PubMedGoogle Scholar
  48. Lindenbaum, J. and Lieber, C. S. Hematologic effects of alcohol in man in the absence of nutritional deficiency. New England Journal of Medicine 281 (1969) 333–338.PubMedCrossRefGoogle Scholar
  49. Linkola, J., and Fyhrquist, F., and Ylikahri, R. Renin, aldosterone, and Cortisol during ethanol intoxication and hangover. Acta Physiologica Scandinavica 106 (1979) 75–82.PubMedCrossRefGoogle Scholar
  50. Linkola, J., Ylikahri, R., Fyhrquist, F., and Wallenius, M. Plasma vasopressin in ethanol intoxication and hangover. Acta Physiologica Scandinavica 104 (1978) 180–187.PubMedCrossRefGoogle Scholar
  51. Lowe, G. D. O. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet 1 (1982) 472–475.PubMedCrossRefGoogle Scholar
  52. Mann, G. V. Diet-heart: End of an era. New England Journal of Medicine 297 (1977) 644–650.PubMedCrossRefGoogle Scholar
  53. Marmot, M. G., Rose, G., Shipley, M. J., and Thomas, B. J. Alcohol and mortality: A U-shaped curve. Lancet 1 (1981) 580–583.PubMedCrossRefGoogle Scholar
  54. Masotti, G. et al. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 2 (1979) 1213–1216.PubMedCrossRefGoogle Scholar
  55. McCarron, D. A., Morris, C. D., and Cole, C. Dietary calcium in human hypertension. Science 217 (1982) 267–269.PubMedCrossRefGoogle Scholar
  56. McDonald, J. T. and Margen, S. Wine versus ethanol in human nutrition. III. Calcium, phosphorus and magnesium balance. American Journal of Clinical Nutrition 32 (1979) 823–833.PubMedGoogle Scholar
  57. Meade, T. W. et al. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. British Medical Journal 1 (1979) 153–156.PubMedCrossRefGoogle Scholar
  58. Meade, T. W. et al. Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1 (1980) 1050–1054.PubMedCrossRefGoogle Scholar
  59. Meagher, R. C., Sieber, F., and Spivak, J. L. Suppression of hematopoietic-progenitor-cell proliferation by ethanol and acetaldehyde. New England Journal of Medicine 307 (1982) 845–849.PubMedCrossRefGoogle Scholar
  60. Miller, G. J. and Miller, N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1 (1975) 16–19.PubMedCrossRefGoogle Scholar
  61. Miller, N. E., Forde, O. H., Thelle, D. S., and Mjos, O. D. The Tromso Heart-Study. High-density lipoprotein and coronary heart-disease: A prospective case-control study. Lancet 1 (1977) 965–968.PubMedCrossRefGoogle Scholar
  62. Morin, Y. and Daniel, P. Quebec beer-drinkers’ cardiomyopathy: Etiologic considerations. Canadian Medical Association Journal J 97 (1967) 926–928.Google Scholar
  63. Ogata, M., Mendelson, J. H., Mello, N. K., and Majchrowicz, E. Adrenal function and alcoholism. II. Catecholamines. Psychosomatic Medicine 33 (1971) 159–180.PubMedGoogle Scholar
  64. Pell S. and D’Alonzo, C. A five-year mortality study of alcoholics. Journal of Occupational Medicine 15 (1973) 120–125.PubMedGoogle Scholar
  65. Post, R. M. and Desforges, J. F. Thrombocytopenia and alcoholism. Annals of Internal Medicine 68 (1968) 1230–1236.PubMedGoogle Scholar
  66. Randall, B. Sudden death and hepatic fatty metamorphosis: A North Carolina survey. Journal of American Medical Association 243 (1980) 1723–1725.CrossRefGoogle Scholar
  67. Reynolds, E. S. An account of the epidemic outbreak of arsenical poisoning occurring in beer-drinkers in the North of England and the Midland Countries in 1900. Lancet 1 (1901) 166–170.CrossRefGoogle Scholar
  68. Rosenberg, L. Alcoholic beverages and myocardial infarction in young women. American Journal of Public Health 71 (1981) 82–85.PubMedCrossRefGoogle Scholar
  69. Salonen, J. T. Personal communication, 1983.Google Scholar
  70. Salzman, E. W. Aspirin to prevent arterial thrombosis. New England Journal of Medicine 307 (1982) 113–115.PubMedCrossRefGoogle Scholar
  71. Saville, P. D. Changes in bone mass with age and alcoholism. Journal of Bone and Joint Surgery 47 (1965) 492–499.PubMedGoogle Scholar
  72. Sime, W. E., Buell, J. C., and Eliot, R. S. Psychophysiological (emotional) stress testing: A potential means of detecting the early reinfarction victim (Abstract). Circulation 60 (1979) (Suppl. II), 11–56.Google Scholar
  73. Spann, J. F., Mason, D. T., Beiser, G. D., and Gold, H. K. Actions of ethanol on the contractile state of the normal and failing cat papillary muscle (Abstract). Clinical Research 16 (1968) 249.Google Scholar
  74. Stason, W. B., Neff, R. K., Miettinen, O. S., and Jick, H. Alcohol consumption and non-fatal myocardial infarction. American Journal of Epidemiology 104 (1976) 603–608.PubMedGoogle Scholar
  75. Stuart, M. J., Gerrard, J. M., and White, J. G. Effect of cholesterol on production of thromboxane B2 by platelets in vitro. New England Journal of Medicine 302 (1980) 6–10.PubMedCrossRefGoogle Scholar
  76. Wilhelmsen, L., Wedel, H., and Tibblin, G. Multivariate analysis of risk factors for coronary heart disease. Circulation 48 (1973) 950–958.PubMedGoogle Scholar
  77. World Health Organization. World Health. Peter Ozorio (ed.) 5 (1982) 30.Google Scholar
  78. Yano, K., Rhoads, G. G., and Kagan, A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. New England Journal of Medicine 297 (1977) 405–409.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Michael H. Criqui

There are no affiliations available

Personalised recommendations